Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Pre-Tax Margin

Income before tax as a percentage of revenue.

Simulations Plus, Inc.NASDAQ: SLP

Pre-Tax Margin · Q2 FY2026 · quarter ended Feb 2026

Pre-tax margin widens to 24.2%

Pre-tax margin was 24.2% in Q2 FY2026, up 8.6 pp from a year earlier. On a trailing-twelve-month basis it was -82.3%, down 93.2 pp year over year. Over 3 fiscal years it narrowed by 115.7 pp.

Context

  • Pre-tax margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
24.2%+19.0 pp QoQ
Last fiscal yearAug 2025
-87.6%-105.3 pp YoY
LTMFeb 2026
-82.3%-93.2 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+8.6 pp——
1 year-105.3 pp——
3 years-115.7 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-87.6%
Year-over-year change
-105.3pp

Pre-Tax Margin vs competitors

How SLP compares with its peers on the latest reported figures

  • SLP's LTM Feb 2026 pre-tax margin of -82.3% is the 4th highest of the 10 companies compared; the peer median is -100.3%.
  • Its year-over-year change of -93.2 pp is the 7th highest of 10, against a peer median of -2.2 pp.
  • Over three fiscal years its change of -115.7 pp compares with a peer median of -9.1 pp.
SLP Competitors Peer median
Pre-Tax Margin for SLP and competitors
Company Period LTM level YoY 3-year change
NRCNational Research CorporationLTM Mar 202610.5% -12.3 pp-15.3 pp
OPRXOptimizeRx CorporationLTM Mar 20268.9% +26.0 pp+24.7 pp
AGLAgilon Health, Inc.LTM Mar 2026-6.4% -2.2 pp-3.0 pp
SLPSimulations Plus, Inc.LTM Feb 2026-82.3% -93.2 pp-115.7 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-98.1% -1.7 pp+82.6 pp
DHDefinitive Healthcare Corp.LTM Mar 2026-100.3% +216.8 pp-67.8 pp
CLLSCellectis S.A.LTM Mar 2026-102.0% +24.5 pp+421.1 pp
ACIUAC Immune S.A.LTM Mar 2026-1788.8% -1604.8 pp-173.9 pp
KRROKorro Bio, Inc.LTM Mar 2026-2935.1% -1124.5 pp—
NAKANakamoto Inc.LTM Mar 2026-7397.8% -7220.8 pp-2800.6 pp
ANROAlto Neuroscience, Inc.FY2025— ——
Peer median (excluding SLP) -100.3%-2.2 pp-9.1 pp

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Revenue46.47M53.91M59.58M70.01M79.18M
Cost of Revenue10.6M10.82M11.63M26.86M32.96M
Gross Profit35.87M43.08M47.95M43.15M46.22M
Gross Margin77.2%79.9%80.5%61.6%58.4%
Research & Development4.05M3.21M4.5M5.75M6.88M
Selling, General & Admin20.57M24.97M34.72M31.27M32.85M
Operating Expenses24.61M28.17M39.22M37.02M116.95M
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
EBITDA14.7M18.69M13.07M18.08M14.7M
EBITDA Margin31.6%34.7%21.9%25.8%18.6%
Operating Income11.25M14.91M8.73M6.13M(70.73M)
Operating Margin24.2%27.7%14.6%8.8%-89.3%
Interest Income201K717K4.13M4.38M722K
Interest Expense22K0000
Other Income / Expenses(168K)204K2.97M6.28M1.35M
Income Before Tax11.09M15.12M11.7M12.41M(69.38M)
Pre-Tax Margin23.9%28.0%19.6%17.7%-87.6%
Income Tax Expense1.3M2.63M1.73M2.46M(4.66M)
Net Income9.78M12.48M9.96M9.95M(64.72M)
Net Margin21.1%23.2%16.7%14.2%-81.7%
EPS (Basic)0.490.620.500.50(3.22)
EPS (Diluted)0.470.600.490.49(3.22)
Weighted Avg Shares20.05M20.2M20.08M19.99M20.1M
Weighted Avg Shares (Diluted)20.74M20.75M20.47M20.3M20.1M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.